MBX vs AMGN: Which Stock is Better?

Side-by-side comparison of Mbx Biosciences Inc and Amgen Inc in 2026

Comparison Updated:

MBX

Mbx Biosciences Inc

$28.00

AMGN

Amgen Inc

$366.21

Key Metrics Comparison

MetricMBXAMGNWinner
Market Cap$1.26B$197.41BAMGN
P/E Ratio3.6525.70MBX
EPS (TTM)$7.67$14.25AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.8%AMGN

Analyze MBX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MBX or AMGN a better investment?

Comparing MBX and AMGN: Mbx Biosciences Inc has a market cap of $1.26B while Amgen Inc has $197.41B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MBX and AMGN?

MBX (Mbx Biosciences Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MBX or AMGN?

Based on P/E ratios, MBX trades at a lower multiple (3.7x vs 25.7x).

Which is growing faster: MBX or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for MBX.

Which company is more profitable: MBX or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for MBX.

Which is the larger company: MBX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $197.41B compared to $1.26B for MBX.

Should I buy MBX or AMGN in 2026?

Both MBX and AMGN have investment merit. MBX trades at $28.00 while AMGN trades at $366.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MBX and AMGN stock?

Key differences: Market Cap ($1.26B vs $197.41B), P/E Ratio (3.7x vs 25.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).

Popular Stock Comparisons